NeueHealth News

Analysts Conflicted on These Healthcare Names: NeueHealth Inc (NEUE), BridgeBio Pharma (BBIO) and Biohaven Ltd. (BHVN)

TipRanksMay 30 18:52

RBC Capital Sticks to Their Hold Rating for NeueHealth Inc (NEUE)

TipRanksMay 30 18:44

NeueHealth Analyst Ratings

BenzingaMar 13 23:10

RBC Capital Sticks to Their Hold Rating for NeueHealth Inc (NEUE)

TipRanksMar 13 18:46

Analysts Offer Insights on Healthcare Companies: Cencora (COR), Cormedix (CRMD) and NeueHealth Inc (NEUE)

TipRanksMar 13 18:45

Analyst Ratings for Bright Health Gr

BenzingaAug 30, 2023 23:01

Morgan Stanley Maintains Underweight on Bright Health Gr, Lowers Price Target to $8

BenzingaAug 30, 2023 22:12

Bright Health Gr Analyst Ratings

BenzingaAug 30, 2023 22:12

RBC Capital Maintains Sector Perform on Bright Health Gr, Raises Price Target to $16

BenzingaAug 14, 2023 20:41

Bright Health Gr Analyst Ratings

BenzingaAug 14, 2023 20:40

Analysts Offer Insights on Healthcare Companies: Amylyx Pharmaceuticals Inc (AMLX), BioNTech SE (BNTX) and Bright Health Group (BHG)

TipRanksAug 11, 2023 17:10

Bright Health Group (BHG) Gets a Sell From Barclays

TipRanksAug 10, 2023 15:26

Analysts Conflicted on These Healthcare Names: Relay Therapeutics (RLAY), Bright Health Group (BHG) and Bausch + Lomb Corporation (BLCO)

TipRanksJul 3, 2023 18:10

Nephron Research Upgrades Bright Health Gr to Buy, Announces $85 Price Target

BenzingaJun 30, 2023 22:38

Barclays Downgrades Bright Health Gr to Underweight, Raises Price Target to $8

BenzingaJun 15, 2023 17:52

Analysts' Opinions Are Mixed on These Healthcare Stocks: RAPT Therapeutics (RAPT), Bright Health Group (BHG) and Premier (PINC)

TipRanksJun 15, 2023 16:10

RBC Capital Maintains Sector Perform on Bright Health Gr, Lowers Price Target to $13

BenzingaMay 30, 2023 21:36

RBC Slashes Price Target on Bright Health Group to $13 From $80, Cites Ongoing Liquidity Concerns, Keeps Sector Perform Rating

MT NewswiresMay 30, 2023 20:12

RETRACTION: May 23 Morgan Stanley Price Target Headline On BHG Has Been Retracted

BenzingaMay 30, 2023 19:19

Morgan Stanley Maintains Underweight on Bright Health Gr, Lowers Price Target to $160

BenzingaMay 23, 2023 19:42